Brief: Annovis Bio Enters Sales Agreement With BofA Securities
31/03/2023 22:26
March 31 (Reuters) - Annovis Bio Inc ANVS.N :
* ANNOVIS BIO - ENTERED SALES AGREEMENT WITH BOFA
SECURITIES,
THINKEQUITY LLC UNDER WHICH CO MAY OFFER AND SELL COMMON STOCK
FOR UP TO $50 MILLION
Source: (https://bit.ly/3M4l9YD)
Further company coverage: ANVS.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Annovis Bio
See all newsAnnovis Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Annovis Bio Q2 loss widens as R&D costs rise
Annovis Bio Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants
U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman